General
Preferred name
CARBENICILLIN INDANYL SODIUM
Synonyms
Carindacillin (sodium) ()
CP-15464-2 ()
CP-15,464-2 ()
Carindacillin sodium salt ()
Carindacillin Sodium ()
Geocillin ()
P&D ID
PD051941
CAS
26605-69-6
Tags
available
prodrug
drug
Drug indication
osteomyelitis
Bacterial infection
Drug Status
approved
Max Phase
4.0
First approval
1972
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Carindacillin (Carbenicillin indanyl) sodium is an orally active and broad-spectrum antimicrobial agent. Carindacillin sodium can be hydrolyzed to Carbenicillin in vivo. Carindacillin sodium can be used for the research of urinary-tract infection[1][2].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
ChEMBL Approved Drugs
ChEMBL Drugs
DrugMAP
DrugMAP Approved Drugs
MedChem Express Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Molecular Weight
516.13
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
5
Aromatic Ring Count
2
cLogP
-1.83
TPSA
115.84
Fraction CSP3
0.38
Chiral centers
4.0
Largest ring
6.0
QED
0.16
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Therapeutic Class
Antiinfective Agents
Pathway
Anti-infection
Target
Bacterial
Source data
